Press release
Precision Oncology Market Outlook: Leading Companies, Innovations, and Future Prospects
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Precision Oncology Market Size, Share & Trends Analysis Report By Product Type (Diagnostics, Therapeutics), By Cancer Type (Breast Cancer, Cervical Cancer, Prostate Cancer, Lung Cancer), By End-use (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Healthcare Data Companies)- Market Outlook And Industry Analysis 2031"
The global Precision Oncology market is estimated to reach over USD 230.71 billion by 2031, exhibiting a CAGR of 10.68% during the forecast period.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1691
Increased attempts to define genes, an increase in online collaboration forums, and developments in cancer biology are the reasons propelling the market's expansion. While the prevalence of life-threatening medical disorders, including cancer and rare diseases, has increased over the past few years, numerous gene treatments, diagnostics, and medications have been introduced in this field. For instance, the Globocan 2021 fact sheet estimates that by 2025, there will be 21.8 million additional instances of cancer. The rising number of cancer cases is anticipated to increase the demand for precision medicine and, in turn, boost the market's expansion.
Furthermore, the development of the industry under review is being fueled by developments in cell biology and technology. For instance, in May 2021, AdventHealth will launch a data-driven precision medicine initiative as part of the expansion of its genomics programme. This initiative will organise and integrate longitudinal patient data with molecular testing data, resulting in the creation of a dataset and disease network models that will aid the healthcare system in better anticipating the onset of diseases and how they will respond to treatments. Thus, these developments are fueling the expansion of the market under study.
List of Prominent Players in the Precision Oncology Market:
• Acrivon Therapeutics
• AstraZeneca
• Bioserve
• Bristol-Myers Squibb
• Eli Lilly
• Exact Sciences Corporation
• F Hoffmann-La Roche AG
• Illumina, Inc.
• Invitae Corporation
• Laboratory Corporation Of America Holding
• Novartis AG
• Qiagen N.V.
• Quest Diagnostics
• Rain Oncology Inc.
• Relay Therapeutics
• Strata Oncology, Inc.
• Thermo Fisher Scientific Inc.
• Variantyx, Inc.
• Xilis, Inc.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-03
Market Dynamics:
Drivers-
Some important drivers of the market's expansion are innovation and the accessibility of new technology. As a standard of treatment for cancer patients, the Cleveland Clinic, for instance, expanded its advanced genomic testing platform in November 2021. Whole-exome sequencing, which analyses every piece of DNA in the genes involved for producing proteins in the body, and RNA sequencing, which evaluates how these proteins are encoded, are both used in this enhanced capacity to screen tumour samples. The market is anticipated to experience rapid expansion throughout the forecast period thanks to developments in precision medicines and diagnostics, as well as game-changing innovations like Next Generation Sequencing (NGS) and big genomic data.
Challenges:
Genetic testing, which is necessary to analyse mutations before prescribing precision medicine, is not covered by insurers. Medical professionals and other healthcare professionals will need to thoroughly understand molecular genetics and biochemistry if precision medication procedures are to become a standard part of healthcare. Despite evidence of significant associations between genotype and illness risk or treatment efficacy, several of the tests' lack of clinical value appeared to be the deciding factor for coverage.
Regional Trends:
The largest market share was in North America. Precision Oncology is becoming more and more in demand in well-established end-user activities, and it is anticipated to experience a sizable CAGR throughout that time. Furthermore, Precision Oncology will have profitable chances in the roofing plans industry thanks to the growing domestic and industrial construction activity in the U.S. Due to improvements in gene mapping technologies, which play a crucial role in the expansion of the domestic industry, the Americas are anticipated to entirely control the global precision medicine market throughout the forecast period.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1691
Recent Developments:
• In December 2022, By the end of 2023, according to Roche, a medication for the uncommon autoimmune condition neuromyelitis optica spectrum disease (NMOSD) would be available in India. Precision medicine is the emphasis of this medication.
Segmentation of Precision Oncology Market-
By Product Type-
• Diagnostics
• Therapeutics
By Cancer Type-
• Breast Cancer
• Colorectal Cancer
• Cervical Cancer
• Prostate Cancer
• Lung Cancer
• Others
By End Use -
• Hospitals & Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies
• Healthcare Data Companies
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
The global Precision Oncology market is estimated to reach over USD 230.71 billion by 2031, exhibiting a CAGR of 10.68% during the forecast period.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1691
Increased attempts to define genes, an increase in online collaboration forums, and developments in cancer biology are the reasons propelling the market's expansion. While the prevalence of life-threatening medical disorders, including cancer and rare diseases, has increased over the past few years, numerous gene treatments, diagnostics, and medications have been introduced in this field. For instance, the Globocan 2021 fact sheet estimates that by 2025, there will be 21.8 million additional instances of cancer. The rising number of cancer cases is anticipated to increase the demand for precision medicine and, in turn, boost the market's expansion.
Furthermore, the development of the industry under review is being fueled by developments in cell biology and technology. For instance, in May 2021, AdventHealth will launch a data-driven precision medicine initiative as part of the expansion of its genomics programme. This initiative will organise and integrate longitudinal patient data with molecular testing data, resulting in the creation of a dataset and disease network models that will aid the healthcare system in better anticipating the onset of diseases and how they will respond to treatments. Thus, these developments are fueling the expansion of the market under study.
List of Prominent Players in the Precision Oncology Market:
• Acrivon Therapeutics
• AstraZeneca
• Bioserve
• Bristol-Myers Squibb
• Eli Lilly
• Exact Sciences Corporation
• F Hoffmann-La Roche AG
• Illumina, Inc.
• Invitae Corporation
• Laboratory Corporation Of America Holding
• Novartis AG
• Qiagen N.V.
• Quest Diagnostics
• Rain Oncology Inc.
• Relay Therapeutics
• Strata Oncology, Inc.
• Thermo Fisher Scientific Inc.
• Variantyx, Inc.
• Xilis, Inc.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-03
Market Dynamics:
Drivers-
Some important drivers of the market's expansion are innovation and the accessibility of new technology. As a standard of treatment for cancer patients, the Cleveland Clinic, for instance, expanded its advanced genomic testing platform in November 2021. Whole-exome sequencing, which analyses every piece of DNA in the genes involved for producing proteins in the body, and RNA sequencing, which evaluates how these proteins are encoded, are both used in this enhanced capacity to screen tumour samples. The market is anticipated to experience rapid expansion throughout the forecast period thanks to developments in precision medicines and diagnostics, as well as game-changing innovations like Next Generation Sequencing (NGS) and big genomic data.
Challenges:
Genetic testing, which is necessary to analyse mutations before prescribing precision medicine, is not covered by insurers. Medical professionals and other healthcare professionals will need to thoroughly understand molecular genetics and biochemistry if precision medication procedures are to become a standard part of healthcare. Despite evidence of significant associations between genotype and illness risk or treatment efficacy, several of the tests' lack of clinical value appeared to be the deciding factor for coverage.
Regional Trends:
The largest market share was in North America. Precision Oncology is becoming more and more in demand in well-established end-user activities, and it is anticipated to experience a sizable CAGR throughout that time. Furthermore, Precision Oncology will have profitable chances in the roofing plans industry thanks to the growing domestic and industrial construction activity in the U.S. Due to improvements in gene mapping technologies, which play a crucial role in the expansion of the domestic industry, the Americas are anticipated to entirely control the global precision medicine market throughout the forecast period.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1691
Recent Developments:
• In December 2022, By the end of 2023, according to Roche, a medication for the uncommon autoimmune condition neuromyelitis optica spectrum disease (NMOSD) would be available in India. Precision medicine is the emphasis of this medication.
Segmentation of Precision Oncology Market-
By Product Type-
• Diagnostics
• Therapeutics
By Cancer Type-
• Breast Cancer
• Colorectal Cancer
• Cervical Cancer
• Prostate Cancer
• Lung Cancer
• Others
By End Use -
• Hospitals & Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies
• Healthcare Data Companies
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
